Skip to content
MenuOpen navigation menu

Head-to-head, mom to mom

CoreAge Rx vs REMEVi

CoreAge Rx and REMEVi both offer GLP-1 telehealth, but they make different trade-offs on signup ease, honest pricing, which meds you can get, state coverage and support. Here they are side-by-side on the Mom-Tested Score — our real-mom rubric.

CoreAge Rx vs REMEVi at a glance

Short answer: CoreAge Rx comes out ahead on state coverage and cancellation, while REMEVi comes out ahead on price, an oral option and visit format. The sections below give the exact figures.

DetailCoreAge RxREMEVi
Semaglutide, standing rateTied to a plan term or membership; not month to month$199 per 4 weeks
Tirzepatide, standing rateTied to a plan term or membership; not month to month$269 per 4 weeks
Yearly differenceNot comparable: no pair of confirmed standing rates in the same billing period
States servedAll 50 states49 states, exact list
Brand-name GLP-1sCompounded onlyCompounded only
Oral or sublingualInjection onlyYes
Visit formatDepends on stateNo video
FDA warning letterNone on recordNone on record
Mom-Tested Score94/10071/100
Full wording for states served and visit format

States served

CoreAge Rx
All 50 states
REMEVi
49 states + DC (not Louisiana)

Visit format

CoreAge Rx
Usually online review; state-specific video or live chat may be required
REMEVi
No video visit required

CoreAge Rx

Higher score

Ranked #1 for moms · Grade A

Best for: Someone considering compounded injections who will confirm the selected plan bill, visit format and refund conditions before paying.

Visit CoreAge Rx
vs

REMEVi

Ranked #58 for moms · Grade C

Best for: Moms who want to see every plan-length tier before committing and value bilingual (EN/ES) support.

Visit REMEVi

The verdict

Higher Mom-Tested Score: CoreAge Rx

CoreAge Rx edges out REMEVi on the Mom-Tested Score, 94 to 71 (A vs C). Someone considering compounded injections who will confirm the selected plan bill, visit format and refund conditions before paying.

REMEVi is still a genuine option — semaglutide injections are $199 every four weeks and tirzepatide $269, with lower rates on prepaid 12- or 24-week plans. Oral semaglutide has its own published price, and care, required labs, supplies and shipping are included. Weigh the six mom factors below against your own priorities.

CoreAge Rx and REMEVi don't publish semaglutide prices in the same billing period, so their headline figures can't be set side by side. That makes intro prices versus what you pay later the better yardstick than any single number. Ask both for the full recurring charge and the supply it covers.

Both stick to compounded medication, so the groundwork is compounded semaglutide versus Ozempic: the same molecule, but not the FDA-approved brand product. REMEVi lists an oral option (a pill or under-the-tongue form) and CoreAge Rx doesn't, and for a pill-versus-shot choice how the Wegovy pill compares with an injection is the fairer yardstick. I walked CoreAge Rx's public signup and wrote up what its intake actually asks, which is useful context for this pairing. However those differences land for you, a prescriber still decides whether treatment is appropriate.

Zooming out from these two, the fastest-signup board ranks the whole roster on the signup factor alone, which is where these two differ most in practice. The Mom-Tested Score gap here, 94 to 71, is an editorial judgment rather than a lab result, so weigh it against your own priorities.

Side-by-side on the six factors

Both providers scored on the same real-mom rubric — the higher side on each factor is marked. See the methodology.

CoreAge Rx REMEVi
Nap-time-easy signup9558
CoreAge
REMEVi
No-surprise pricing9685
CoreAge
REMEVi
Both meds available9478
CoreAge
REMEVi
Works in your state9684
CoreAge
REMEVi
Support you can reach8872
CoreAge
REMEVi
Cancel without a fight9348
CoreAge
REMEVi

Price: the gap per billing period and per year

REMEVi lists semaglutide at $199 per 4 weeks, but CoreAge Rx's lowest recorded figure depends on a plan term, prepayment or a required membership, so there is no month-to-month gap to calculate.

REMEVi lists tirzepatide at $269 per 4 weeks, but CoreAge Rx's lowest recorded figure depends on a plan term, prepayment or a required membership, so there is no month-to-month gap to calculate.

No annualized difference is calculated for this pair: it needs two confirmed standing rates in the same billing period.

States: where each one serves

From the state lists each provider publishes, CoreAge Rx serves 50 states and REMEVi serves 49, and 49 states are covered by both.

Only CoreAge Rx covers Louisiana.

Medications: brand, compounded, oral and molecules

CoreAge Rx lists semaglutide and tirzepatide as compounded medication. REMEVi lists semaglutide and tirzepatide as compounded medication and an oral or sublingual form.

REMEVi lists an oral or sublingual option; CoreAge Rx is injection only.

Visit format, what the price includes and signup

Visit format: CoreAge Rx is recorded as "Usually online review; state-specific video or live chat may be required" and REMEVi as "No video visit required".

Both prices include the clinician consult, the medication and shipping, so inclusions do not separate them.

FDA warning letters and where the scores differ most

Neither CoreAge Rx nor REMEVi has an FDA warning letter of its own on record in our review.

On cancellation (Cancel without a fight), CoreAge Rx scores 93 and REMEVi scores 48, a 45-point gap in favor of CoreAge Rx.

On signup ease (Nap-time-easy signup), CoreAge Rx scores 95 and REMEVi scores 58, a 37-point gap in favor of CoreAge Rx.

Which one fits you

Pick CoreAge Rx if

  • You live in Louisiana, where REMEVi does not list service.
  • You weigh cancellation most: it scores 93 against 48 on our rubric.

Pick REMEVi if

  • You want a price you can confirm month to month, which CoreAge Rx does not have on record.
  • You want an oral or sublingual form instead of an injection, which CoreAge Rx does not list.
  • You want to start without a live video visit, which CoreAge Rx does not promise.

These lines come only from the differences above. If a line is missing for one side, the recorded data gives it no edge on that point, and prices and terms change, so confirm on each provider's own site.

CoreAge Rx

Ranked #1 · Grade A

What we like

  • Advertised $79 semaglutide and $129 tirzepatide monthly prices stay the same at every listed dose
  • Both semaglutide and tirzepatide on one account, so you're not locked to one molecule
  • One-time purchases and optional subscriptions are described separately in its current policies

The caveats

  • Advertised monthly figures do not establish the selected plan duration or upfront payment; longer terms can have different effective monthly rates
  • A $50–$100 consultation fee included in the treatment price is non-refundable after review, even if treatment is declined; this conflicts with the general FAQ’s 100% refund statement
  • Canceling a subscription stops future renewals; a prescription approved and sent to the pharmacy is generally final even before shipment

REMEVi

Ranked #58 · Grade C

What we like

  • All 4-, 12- and 24-week plans have public prices and full prepaid totals
  • The same plan price applies at every dose and renewal
  • English and Spanish care coordination

The caveats

  • No brand-name (FDA-approved) option
  • The lowest rate requires 24 weeks paid upfront: $954 for semaglutide, $1,350 for tirzepatide or $1,290 for oral semaglutide
  • Four-week billing means 13 cycles in 52 weeks; cancellation needs at least 72 hours' notice

CoreAge Rx vs REMEVi: quick answers

Which is cheaper, CoreAge Rx or REMEVi?

REMEVi lists semaglutide at $199 per 4 weeks, but CoreAge Rx's lowest recorded figure depends on a plan term, prepayment or a required membership, so there is no month-to-month gap to calculate. REMEVi lists tirzepatide at $269 per 4 weeks, but CoreAge Rx's lowest recorded figure depends on a plan term, prepayment or a required membership, so there is no month-to-month gap to calculate. No annualized difference is calculated for this pair: it needs two confirmed standing rates in the same billing period.

Does CoreAge Rx or REMEVi serve more states?

From the state lists each provider publishes, CoreAge Rx serves 50 states and REMEVi serves 49, and 49 states are covered by both. Only CoreAge Rx covers Louisiana.

Do CoreAge Rx and REMEVi require a video visit?

Visit format: CoreAge Rx is recorded as "Usually online review; state-specific video or live chat may be required" and REMEVi as "No video visit required". Their visit formats differ, so check which one fits your week before you pay.

Which has the wider medication lineup, CoreAge Rx or REMEVi?

CoreAge Rx lists semaglutide and tirzepatide as compounded medication. REMEVi lists semaglutide and tirzepatide as compounded medication and an oral or sublingual form. REMEVi lists an oral or sublingual option; CoreAge Rx is injection only.

Has CoreAge Rx or REMEVi received an FDA warning letter?

Neither CoreAge Rx nor REMEVi has an FDA warning letter of its own on record in our review.

Some providers we list are partners, and we may be paid when you sign up through our links, at no cost to you. That can affect which providers we feature. Pricing, states and verification reflect each provider's public disclosures at last review; the Mom-Tested Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing CoreAge Rx and REMEVi against other providers I reviewed for moms.

Or browse the full comparison hub.